Add BrightSurf on Google Email

University of Rochester Medical Center


In landmark study, immunotherapy boosts survival of advanced Hodgkin lymphoma

A new treatment approach using immunotherapy has shown promising results in treating advanced Hodgkin lymphoma, with a remarkable 92% survival rate. The innovative clinical trial, led by Wilmot Director Jonathan Friedberg, also minimizes long-term side effects and toxicities.

SourceUniversity of Rochester Medical Center·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 16, 2024

Antibodies in breast milk provide protection against common GI virus

A study by researchers at the University of Rochester Medical Center found that high levels of specific antibodies in breast milk provide protection against rotavirus, a common gastrointestinal disease. The findings highlight the importance of optimized breastfeeding practices to improve infant health globally.

SourceUniversity of Rochester Medical Center·JournalJournal of Clinical Investigation·TypeData/statistical analysis·DateOct 1, 2024

Measuring “quality of life” is an important trend in cancer care

A nationwide study found that brentuximab vendotin significantly improved the quality of life for young patients with high-risk pediatric Hodgkin lymphoma. Nearly 44% of patients reported poor quality of life before treatment, but researchers saw significant improvement as treatment progressed.

SourceUniversity of Rochester Medical Center·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateAug 5, 2024

Liver transplant outperforms other therapies for colorectal cancer that has spread to the liver

A study published in JAMA Surgery shows that liver transplants significantly improve progression-free survival rates for patients with unresectable colorectal liver metastases compared to other therapies. At three years, 90% of transplant patients remained cancer-progression free, whereas only 42% of those receiving alternative treatme...

SourceUniversity of Rochester Medical Center·JournalJAMA Surgery·TypeObservational study·DateJul 30, 2024

Researchers find intriguing new tool for tendon healing: nanoparticles for precision drug delivery

A team of researchers has created a new approach to deliver drugs precisely to surgically repaired tendons using nanoparticles, reducing scar tissue formation and improving function. The treatment targets the Acp5 gene, which is highly expressed at the injury site, and delivers medication directly to the healing tendon.

SourceUniversity of Rochester Medical Center·JournalScience Advances·DateJun 27, 2024

Can diet help with advanced breast cancer? All indications are positive, researchers say

A small study at the University of Rochester Medical Center found that women with stage 4 breast cancer who followed a whole-foods plant-based diet experienced significant weight loss, improved cholesterol levels, and reduced fatigue. The diet also showed promise in reducing inflammation and changes in blood levels of amino acids.

SourceUniversity of Rochester Medical Center·JournalBreast Cancer Research and Treatment·TypeRandomized controlled/clinical trial·DateMay 22, 2024

Air quality in schools: Shielding kids with intellectual and developmental disabilities from COVID

Researchers discovered that good airflow and filtration in schools can significantly reduce COVID-19 infections among children with intellectual and developmental disabilities. The study found that classrooms with high-efficiency air filters had lower infection rates, highlighting the importance of improved ventilation systems.

SourceUniversity of Rochester Medical Center·JournalPLOS ONE·TypeObservational study·DateApr 3, 2024

Modifying chemotherapy treatment can make life better for older adults with cancer

Research shows that lowering doses and adjusting chemotherapy schedules for older adults with advanced cancer can reduce toxic side effects and preserve daily functions. Over 30% of patients benefited from treatment regimen modifications, with a 15% reduced risk of serious clinician-rated toxic effects.

SourceUniversity of Rochester Medical Center·JournalJAMA Network Open·TypeData/statistical analysis·DateFeb 16, 2024

Researchers identify path to prevent cognitive decline after radiation

Researchers at the University of Rochester Medical Center find that microglia can trigger cognitive deficits after radiation exposure, potentially targeting them for therapy development. Mice studies showed that blocking a specific pathway in microglia prevented cognitive decline, offering hope for improving patients' quality of life.

SourceUniversity of Rochester Medical Center·JournalInternational Journal of Radiation Oncology*Biology*Physics·DateJan 3, 2024

Calcium channel blockers key to reversing myotonic dystrophy muscle weakness, study finds

Researchers found that calcium channel blockers can reverse symptoms of myotonic dystrophy in animal models, a potential new treatment for the disease. The study suggests that targeting the calcium channel could improve muscle function and health, offering hope for patients with this debilitating condition.

SourceUniversity of Rochester Medical Center·JournalJournal of Clinical Investigation·DateJan 2, 2024

Science backs mind-body tools like meditation and music for cancer-related anxiety

National guidelines recommend mindfulness meditation, yoga, and music therapy for cancer patients experiencing anxiety and depression. The guidelines are based on strong evidence from clinical studies, providing a comprehensive approach to managing these common side effects of cancer treatment.

SourceUniversity of Rochester Medical Center·JournalJournal of Clinical Oncology·TypeLiterature review·DateAug 15, 2023

Health is where the home is: study shows pediatrician and family collaboration can address obesity

A new study published in the Journal of the American Medical Association found that pediatrician and family collaboration can address obesity. The study showed that three times as many children in the treatment group had a clinically meaningful reduction in body mass index (BMI), resulting in improved cardiometabolic outcomes.

SourceUniversity of Rochester Medical Center·JournalJAMA·TypeRandomized controlled/clinical trial·DateJun 27, 2023

A chance observation finds potential hearing biomarker for Alzheimer’s disease

Scientists at the University of Rochester Medical Center discovered a link between Alzheimer's disease and hearing loss in mice, finding that plaque location in the brain may contribute to hearing decline. The study suggests that tracking disease progression through amyloid PET imaging could be a potential biomarker for hearing loss.

SourceUniversity of Rochester Medical Center·JournalFrontiers in Neuroscience·DateJun 7, 2023